Back to Search
Start Over
Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo
- Source :
- Nature Communications, Vol 13, Iss 1, Pp 1-9 (2022)
- Publication Year :
- 2022
- Publisher :
- Nature Portfolio, 2022.
-
Abstract
- Next-generation lipid nanoparticles that target non-hepatocytes could be important clinical tools. Using in vivo DNA barcoding, the authors identify piperazine-containing lipids deliver mRNA to immune cells without targeting ligands.
- Subjects :
- Science
Subjects
Details
- Language :
- English
- ISSN :
- 20411723
- Volume :
- 13
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Nature Communications
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.3a05515d75242a7919700c5dcde3bf7
- Document Type :
- article
- Full Text :
- https://doi.org/10.1038/s41467-022-32281-5